Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 511-514

  Fundytus, Marian E ^a,b   Coderre, Terence J ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

(1S,3R) ACPD; (1S,3S) ACPD; DCG IV; Dependence; DHPG; L AP4; Metabotropic glutamate receptor; Morphine; Precipitated withdrawal

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; GLUTAMATE RECEPTOR AGONIST; GLYCINE DERIVATIVE; METABOTROPIC RECEPTOR; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; WITHDRAWAL SYNDROME;

ANIMALS; EXCITATORY AMINO ACID AGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031011136     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701174     Document Type: Article

References (32)

1. BARG, J., BELCHEVA, M.M. & COSCIA, C.J. (1992). Evidence for the implication of phosphoinositol signal transduction in mu-opioid inhibition of DNA synthesis. J. Neurochem., 59, 1145-1152.
2. 2+ mobilization in rat C6 glioma cells. J. Neurosci., 14, 5858-5864.
3. BARG, J., NAH, S.Y., LEVY, R., SAYA, D. & VOGEL, Z. (1993). Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures. Brain Res., 629, 109-114.
4. BUISSON, A. & CHOI, D.W. (1995). The inhibitory mGluR agonist, s-4-carboxy-3-hydroxy-phenylglycine, selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology, 34, 1081-1087.
5. BUSQUETS, X., ESCRIBA, P. V., SASTRE, M. & GARCIA-SEVILLA, J.A. (1995) Loss of protein kinase C-alpha beta in brain of heroin addicts and morphine-dependent rats. J. Neurochem., 64, 247-252.
6. CHILDERS, S.R. (1991). Opioid receptor-coupled second messenger systems. Life Sci., 48, 1991-2003.
7. DIXON, W., TING, Y.-W. & CHANG, P.L. (1990). The effects of morphine on norepinephrine-stimulated phosphatidylinositol response in rat cerebral cortex. Prog. Clin. Biol. Res., 328, 279-282.
8. FUNDYTUS, M.E. & CODERRE, T.J. (1994). Morphine dependence is affected by activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors. Br. J. Pharmacol., 113, 1215-1220.
9. 2+-release or PKC activation significantly reduces the development of morphine dependence. Eur. J. Pharmacol., 300, 173-181.
10. FUNDYTUS, M.E., RITCHIE, J. & CODERRE, T.J. (1997). Attenuation of morphine withdrawal symptoms by subtype selective metabotropic glutamate receptor antagonists. Br. J. Pharmacol., 120, 1015-1020.
11. HAYASHI, Y., SEKIYAMA, N., NAKANISHI, S., JANE, D.E., SUNTER, D.C., BIRSE, E.F., UDVARHELYI, P.M. & WATKINS, J.C. (1994). Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes. J. Neurosci., 14, 3370-3377.
12. ISHIDA, M., SAITOH, T., SHIMAMOTO, K., OHFUNE, Y. & SHINOZAKI, H. (1993). A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord. Br. J. Pharmacol., 109, 1169-1177.
13. JOHNSON, P.S., WANG, J.B., WANG, W.F. & UHL, G.R. (1994). Expressed mu opiate receptor couples to adenylate cyclase and phosphatidylinositol turnover. NeuroReport, 5, 507-509.
14. MANSOUR, A., FOX, C.A., AKIL, H. & WATSON, S.J. (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci., 18, 22-29.
15. MAO, J.R., PRICE, D.D. & MAYER, D.J. (1995). Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain, 62, 259-274.
16. MASU, M., NAKAJIMA, Y., MORIYOSHI, K., ISHII, T., AKAZAWA, C. & NAKANISHI, S. (1995). Molecular characterization of NMDA and metabotropic glutamate receptors. Ann. New York Acad. Sci., 707, 153-164.
17. NAKAJIMA, Y., IWAKABE, H., AKAZAWA, C., NAWA, H., SHIGEMOTO, R., MIZUNO, N. & NAKANISHI, S. (1993). Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J. Biol. Chem., 268, 868-873.
18. NAKANISHI, S. (1992). Molecular diversity of glutamate receptors and implications for brain function. Science, 258, 597-603.
19. NARITA, M., FENG, Y., HOSKINS, B. & HO, I.K. (1994). Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res., 650, 175-179.
20. OKAMOTO, N., HORI, S., AKAZAWA, C., HAYASHI, Y., SHIGEMOTO, R., MIZUNO, N. & NAKANISHI, S. (1994). Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J. Biol. Chem., 269, 1231-1236.
21. PALMER, E., MONAGHAN, D.T. & COTMAN, C.W. (1989). Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor. Eur. J. Pharmacol., 166, 585-587.
22. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. San Diego, California: Academic Press Inc.
23. PELLEGRINI-GIAMPIETRO, D.E., RUGGIERO, M., GIANNELLI, S., CHIARUGI, S. & MORONI, F. (1988). Morphine withdrawal in vitro: potentiation of agonist-dependent polyphosphoinositide breakdown. Eur. J. Pharmacol. 149, 297-306.
24. PIN, J.-P. & DUVIOSIN, R. (1995). Review: Neurotransmitter receptors I. The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 34, 1-26.
25. SCHOEPP, D.D. & CONN, P.J. (1993). Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci., 14, 13-25.
26. SCHOEPP, D.D., GOLDSWORTHY, J., JOHNSON, B.G., SALHOFF, C.R. & BAKER, S.R. (1994). 3,5-Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. J. Neurochem., 63, 769-772.
27. SCHOEPP, D.D., JOHNSON, B.G. & MONN, J.A. (1992). Inhibition of cyclic AMP formation by a selective metabotropic glutamate receptor agonist. J. Neurochem., 58, 1184-1186.
28. SCHOEPP, D.D., JOHNSON, B.G., SALHOFF, C.R., MCDONALD, J.W. & JOHNSON, M.V. (1991a). In vitro and in vivo pharmacology of trans- and cis-(±)-1-amino-1,3-cyclo-pentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects. J. Neurochem., 56, 1789-1796.
29. SCHOEPP, D.D., JOHNSON, B.G., TRUE, R.A. & MONN, J.A. (1991b). Comparison of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD)- and 1R,3S-ACPD-stimulated brain phosphoinositide hydrolysis. Eur. J. Pharmacol., 207, 351-353.
30. TRUJILLO, K.A. & AKIL, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 85-87.
31. TRUJILLO, K.A. & AKIL, H. (1994). Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res., 633, 178-188.
32. WATKINS, J.C. & COLLINGRIDGE, G.L. (1994). Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. Trends Pharmacol. Sci., 15, 333-342.